- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/14 - Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Patent holdings for IPC class A61P 25/14
Total number of patents in this class: 1772
10-year publication summary
|
46
|
58
|
104
|
131
|
122
|
116
|
137
|
117
|
119
|
82
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2707 |
32 |
| Taisho Pharmaceutical Co., Ltd. | 866 |
31 |
| Neurocrine Biosciences, Inc. | 429 |
28 |
| Auspex Pharmaceuticals, Inc. | 180 |
22 |
| Daiichi Sankyo Company, Limited | 1886 |
20 |
| Kyoto University | 2808 |
17 |
| Sage Therapeutics, Inc. | 365 |
17 |
| Prilenia Neurotherapeutics Ltd. | 89 |
16 |
| F. Hoffmann-La Roche AG | 7942 |
13 |
| The Regents of the University of California | 20035 |
13 |
| PTC Therapeutics, Inc. | 487 |
13 |
| Sumitomo Dainippon Pharma Co., Ltd. | 212 |
13 |
| Vanderbilt University | 1913 |
13 |
| Adeptio Pharmaceuticals Limited | 21 |
13 |
| Voyager Therapeutics, Inc. | 265 |
12 |
| Sumitomo Pharma Co., Ltd. | 595 |
12 |
| Duke University | 3084 |
11 |
| Ovid Therapeutics Inc | 167 |
11 |
| Hoffmann-La Roche Inc. | 3456 |
10 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 833 |
10 |
| Other owners | 1445 |